FGF23 and hyperphosphatemia: Conversely, other mutations in FGF23 which result in an increase in FGF23 processing and subsequent decrease in circulating intact FGF23 levels lead to familial tumoral calcinosis (FTC), a human disease characterized by hyperphosphatemia and heterotopic calcification (10–12).